Get started
Work

Supplementary Figure 1 from Higher Risk of Infections with PI3K–AKT–mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure 1. Occurence of infection during treatment with single agent PI3K-AKT-mTOR inhibitors
DOI: 10.1158/1078-0432.22454603
Authors: Saeed Rafii, Desamparados Roda, Elena Geuna, Begona Jimenez, Karim Rihawi, Marta Capelan, Timothy A. Yap, L. Rhoda Molife, Stanley B. Kaye, Johann S. de Bono, Udai Banerji
Language: English
Open Access status: gold
OpenAlex ID: W4362433792
Cites:
Cited by:
Related to: 10